| Bioactivity | EEKLIVVAF is a pepitide, can be recognized on HLA-B44 by the anti-melanoma cytolytic T-cell (CTL) clone LB33- CTL-159/5[1][2]. |
| Invitro | EEKLIVVAF can be recognized by CTL clone on C1RB*4402 and C1R-B*4403 cells, and (45 ng/mL and 160 ng/mL, respectively; 30 min; 20 ℃) shows the ability to compete with a standard peptide for binding to HLA-B*4402 and HLA-B*4403 molecules[1]. |
| Name | EEKLIVVAF |
| CAS | 188818-21-5 |
| Shortening | EEKLIVVAF |
| Formula | C50H82N10O14 |
| Molar Mass | 1047.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
EEKLIVVAF
CAS: 188818-21-5 F: C50H82N10O14 W: 1047.24
EEKLIVVAF is a pepitide, can be recognized on HLA-B44 by the anti-melanoma cytolytic T-cell (CTL) clone LB33- CTL-159/5.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.